Iodosorb 10mg (B4)

Iodosorb* ointment is a sterile formulation of cadexomer iodine. When applied to the wound, Iodosorb cleans it by absorbing fluids, removing exudate, pus and debris and forming a gel over the wound surface. As the ointment swells, iodine is released, killing bacteria in the wound.

• Iodosorb ointment contains 50% cadexomer iodine and 50% ointment base.
• Iodosorb changes colour from brown to yellow when the dressing requires changing.

Helps promote wound healing

• Effectively removes pus and debris
• Helps promote a clean wound-healing environment
• Gel formed over the wound helps to facilitate moist healing
• Accelerated healing rates can lead to earlier patient discharges

Patient comfort

• Non-adherent to wounds, reducing trauma at dressing changes and protecting delicate epithelium.
• Cadexomer iodine absorbs 6 to 8 times its own weight in fluid, limiting the number of dressing changes required.
• Helps reduce odour associated with heavily contaminated wounds.

• Should not be used in patients with know or suspected iodine sensitivity, Hashimoto’s thyroiditis or prior history of Graves Disease, or in the case of non-toxic nodular goitre.
• Patients with a past history of any thyroid disorder are more susceptible to alteration in thyroid metabolism with chronic Iodosorb therapy.
• Iodine may be absorbed systemically especially when large wounds are treated.
• In endemic goitre there have been isolated reports of hyperthyroidism associated with Iodosorb.
• Iodine may potentially interact with lithium, sulphafurazoles and sulphonylureas therefore administration is not recommended.
• Should not be used pregnant or lactating women.
• Adherent crust may form when the dressing is changed with significant frequency.
• Use Iodosorb Powder for very moist wounds.